Skip to main content

CITIGROUP INC

Position in ANIP — Ani Pharmaceuticals Inc

CIK 831001 NEW YORK, NY

Position in ANIP

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$11,292,102
+$196,894 QoQ
Shares Held
136,411
-5.5% QoQ
Ownership
0.594%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 305 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Derivatives in ANIP

reported options exposure · as of Dec 31, 2020
CallValue
$5,808
CallShares
200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. ANIP ranks #10 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANIP

Export CSV
33 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,292,102 136,411
2026-03-31 $11,095,208 144,281
2025-12-31 $13,575,390 171,971
2025-09-30 $9,524,567 103,980
2025-06-30 $1,276,223 19,559
2025-03-31 $1,899,503 28,372
2024-12-31 $1,955,198 35,369
2024-09-30 $1,640,530 27,498
2024-06-30 $1,047,026 16,442
2024-03-31 $1,256,643 18,178
2023-12-31 $788,336 14,297
2023-09-30 $497,341 8,566
2023-06-30 $574,742 10,677
2023-03-31 $250,037 6,295
2022-12-31 $320,673 7,971
2022-09-30 $222,890 6,935
2022-06-30 $232,167 7,825
2022-03-31 $351,823 12,516
2021-12-31 $397,900 8,635
2021-09-30 $195,672 5,962
2021-06-30 $230,734 6,583
2021-03-31 $52,836 1,462
2020-12-31 $5,808 200
2020-12-31 $84,390 2,906
2020-09-30 $14,105 500
2020-09-30 $42,117 1,493
2020-09-30 $16,926 600
2020-06-30 $22,638 700
2020-06-30 $161,732 5,001
2020-06-30 $6,468 200
2020-03-31 $69,258 1,700
2020-03-31 $28,518 700
2020-03-31 $181,211 4,448